Investment
Features
FeesSafety
Academy
More
Pluang+

Tema Space Innovators ETF (NASA) tops $1B AUM in 37 days, driven by SpaceX IPO excitement.

Market News
24 May 2026
Blockonomi
View Source
Bullish
pluang ai news

The Tema Space Innovators ETF (NASA) reached $1.27 billion in assets under management just 37 trading days after its March 31 launch, becoming the largest space sector ETF. This rapid growth was fueled by a $375 million inflow following SpaceX's S-1 filing ahead of its anticipated IPO. NASA is unique as the only space ETF offering access to SpaceX shares through a special vehicle, though SpaceX's portfolio weight has dropped from 10.3% to 4.6% due to capital inflows diluting private holdings. Despite this, NASA outperformed competitors with a 46% return since launch, highlighting strong investor demand for space industry exposure before SpaceX goes public.

More News

Bunzl PLC beats earnings estimates, raises margin forecast, and launches £500M share buyback.

Bunzl PLC beats earnings estimates, raises margin forecast, and launches £500M share buyback.

Bunzl PLC reported stronger-than-expected financial results with an EPS of $0.60, surpassing the $0.56 consensus. Revenue reached $8.04 billion, driven by a 3.2% underlying growth, especially in North America. The operating margin improved to 7.3%, p...

Company Fundamentals
Bullish
1 hour ago
Palo Alto Networks expects strong Q3 earnings and revenue growth amid positive cybersecurity trends.

Palo Alto Networks expects strong Q3 earnings and revenue growth amid positive cybersecurity trends.

Palo Alto Networks is set to report strong earnings per share (EPS) of $0.98 and revenue of $3.35 billion for the upcoming quarter, reflecting significant growth from last year. Investor optimism is driven by robust cybersecurity sector trends and a ...

Company Fundamentals
Bullish
1 hour ago
Medtronic beats Q3 earnings and revenue estimates, boosts outlook with $700M investment in Heart Tech and Robotics.

Medtronic beats Q3 earnings and revenue estimates, boosts outlook with $700M investment in Heart Tech and Robotics.

Medtronic reported Q3 earnings per share of $1.45, surpassing estimates of $1.39, and revenue of $9.76 billion, above the $9.55 billion consensus. The strong financial results reflect broad demand for its cardiovascular devices. The company raised it...

Company Fundamentals
Bullish
2 hours ago
Dell Technologies set for record Q2 earnings driven by AI server demand and strong revenue growth.

Dell Technologies set for record Q2 earnings driven by AI server demand and strong revenue growth.

Dell Technologies is expected to report record second-quarter earnings with EPS around $4.91 and revenue near $44.89 billion, fueled by high demand for its AI-optimized servers. This would mark a significant increase from last year's $29.78 billion a...

Company Fundamentals
Bullish
2 hours ago
Protagonist Therapeutics' price target raised to $180 after FDA approves new drug MIMRYLO.

Protagonist Therapeutics' price target raised to $180 after FDA approves new drug MIMRYLO.

Protagonist Therapeutics saw its stock price target raised to $180 by Barclays following the FDA approval of MIMRYLO, a first-in-class drug for polycythemia vera. The approval was based on strong Phase 3 trial results with 76.9% patient response, tri...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App